These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mineralcorticoid receptor blockers in chronic kidney disease. Erraez S; López-Mesa M; Gómez-Fernández P Nefrologia (Engl Ed); 2021; 41(3):258-275. PubMed ID: 36166243 [TBL] [Abstract][Full Text] [Related]
5. Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Bianchi S; Bigazzi R; Campese VM Am J Kidney Dis; 2005 Jul; 46(1):45-51. PubMed ID: 15983956 [TBL] [Abstract][Full Text] [Related]
15. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria. Morales E; Gutiérrez E; Caro J; Sevillano A; Rojas-Rivera J; Praga M Nefrologia; 2015; 35(6):554-61. PubMed ID: 26519114 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms. Epstein M; Kovesdy CP; Clase CM; Sood MM; Pecoits-Filho R Am J Kidney Dis; 2022 Nov; 80(5):658-666. PubMed ID: 36057467 [TBL] [Abstract][Full Text] [Related]
18. [Roll of aldosterone in pathogenesis of kidney disorders]. Kitamura K; Tomita K Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1428-34. PubMed ID: 16097603 [No Abstract] [Full Text] [Related]
19. Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Lu Y; Ku E; Campese VM Curr Hypertens Rep; 2010 Aug; 12(4):303-6. PubMed ID: 20596805 [TBL] [Abstract][Full Text] [Related]
20. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy? Werner C; Pöss J; Böhm M Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]